BasemMourad LabibMishrikyMD
Internal Medicine • Raleigh, NCFellowship-trained Diabetologist, Obesity Medicine Specialist
Dr. Mishriky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7200 Creedmoor Rd
Suite 208
Raleigh, NC 27613Phone+1 919-701-5157
Summary
- Fellowship trained in Diabetes at Vidant Medical Center / East Carolina University from July 2016 till June 2017. I was mentored by a great mentor, Dr. Robert Tanenberg.
Through my passion in diabetes, I practice in a specialized diabetes clinic at ECU Physicians to serve patients with type 1 diabetes, type 2 diabetes, gestational diabetes, patients on insulin pumps, patients with insulin resistance, patients on continuous glucose monitor (CGM), and diabetic neuropathy.
Education & Training
ECU Health Medical Center/East Carolina UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 2016 - 2017
ECU Health Medical Center/East Carolina UniversityResidency, Internal Medicine, 2014 - 2016- ECU Health Medical Center/East Carolina UniversityInternship, Internal Medicine, 2013 - 2014
Cairo University School of MedicineClass of 2007
Certifications & Licensure
NC State Medical License 2013 - 2024
SC State Medical License 2022 - 2023- American Board of Internal Medicine Internal Medicine
- American Board of Obesity Medicine Obesity Medicine
Awards, Honors, & Recognition
- Teaching Recognition Award by 3rd Year Medical Residents East Carolina University, 2019
- Teaching Recognition Award by 2nd Year Medical Residents East Carolina University, 2018
- Best Clincal Research Poster Annual North Carolina ACP, 2017
- Join now to see all
Clinical Trials
- Trial to Assess Chelation Therapy 2 Start of enrollment: 2016 Oct 01
- A Trial Comparing the Efficacy and Safety of Insulin Degludec and Insulin Glargine 300 Units/mL in Subjects With Type 2 Diabetes Mellitus Inadequately Treated With Basal Insulin With or Without Oral Antidiabetic Drugs Start of enrollment: 2017 Mar 13
Publications & Presentations
PubMed
- 220 citationsImpact of pregabalin on acute and persistent postoperative pain: a systematic review and meta-analysisBasem M. Mishriky, Nathan H. Waldron, Ashraf S. Habib
British Journal of Anaesthesia. 2015-01-01 - 67 citationsThe efficacy and safety of DPP4 inhibitors compared to sulfonylureas as add-on therapy to metformin in patients with Type 2 diabetes: A systematic review and meta-anal...Basem M. Mishriky, Doyle M. Cummings, Robert J. Tanenberg
Diabetes Research and Clinical Practice. 2015-08-01 - 126 citationsTransversus abdominis plane block for analgesia after Cesarean delivery: a systematic review and meta-analysis.Basem M. Mishriky, Ronald B. George, Ashraf S. Habib
Canadian Journal of Anaesthesia = Journal Canadien D'anesthesie. 2012-05-24
Press Mentions
CV Benefit of GLP-1 Agonists and SGLT2 Inhibitors Misleading for Black Patients? ADAJuly 13th, 2019
Do Black Patients with Type 2 Diabetes Gain Cardiac Benefit from the SGLT2 and GLP-1 Drugs?June 25th, 2019
CV Benefit of Newer Type 2 Diabetes Drugs Not Seen in Black PatientsMarch 24th, 2019
Professional Memberships
- Member
- Member
- Endocrine SocietyMember
- American College of DiabetologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
